Valentina Cirello
Overview
Explore the profile of Valentina Cirello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer
Cirello V, Colombo C, Tosi D, Manzo A, Borghi M, Gianelli U, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39891677
Context: No data are available about the possible association of TP53 mutations and the response to multikinase inhibitors (MKIs) in thyroid cancer (TC). Objective: We evaluated the impact of TP53...
2.
Cirello V, Lugaresi M, Moneta C, Dufour P, Manzo A, Carbone E, et al.
Eur Thyroid J
. 2024 Apr;
13(3).
PMID: 38657654
Objective: The aim was to evaluate the possible association between some endocrine disruptive chemicals and thyroid cancer (TC) in an Italian case-control cohort. Methods: We enrolled 112 TC patients and...
3.
Cirello V, Gambale C, Nikitski A, Masaki C, Roque J, Colombo C
Panminerva Med
. 2024 Apr;
66(2):155-173.
PMID: 38576304
Poorly differentiated thyroid carcinoma (PDTC) is a rare and extremely aggressive tumor, accounting for about 2-15% of all thyroid cancer. PDTC has a distinct biological behavior compared to well-differentiated and...
4.
Cirello V, Lugaresi M, Manzo A, Balla E, Fratianni G, Solari F, et al.
Infection
. 2023 May;
51(4):1079.
PMID: 37170056
No abstract available.
5.
Cirello V, Lugaresi M, Manzo A, Balla E, Fratianni G, Solari F, et al.
Infection
. 2023 Mar;
51(4):1071-1078.
PMID: 36857020
Purpose: The clinical outcome of COVID-19 disease is worse in males, and the reasons of this gender disparity are currently unclear, though evidences point to a combination of biological and...
6.
Muzza M, Pogliaghi G, Colombo C, Carbone E, Cirello V, Palazzo S, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497339
Oxidative stress (OS) can have an impact in the pathogenesis and in the progression of thyroid cancer. We investigated the levels of reactive oxygen species (ROS) in 50 malignant and...
7.
Colombo C, Pogliaghi G, Tosi D, Muzza M, Bulfamante G, Persani L, et al.
Front Oncol
. 2022 Sep;
12:949098.
PMID: 36119511
To date, the molecular mechanisms that underline aggressiveness and resistance to tyrosine kinase inhibitors in some thyroid carcinomas (TCs) are not known yet. We report the case of a young...
8.
Cirello V, Grassi E, Pogliaghi G, Ghiandai V, Ermellino L, Muzza M, et al.
Sci Rep
. 2022 May;
12(1):8608.
PMID: 35597845
FAM83B has been recently identified as an oncogene, but its role in thyroid cancers (TC) is still unclear. We examined the expression of FAM83B and its possible involvement in cell...
9.
Radetti G, Rigon F, Salvatoni A, Campi I, de Filippis T, Cirello V, et al.
Eur Thyroid J
. 2022 Jan;
11(2).
PMID: 35060923
Introduction: Patients with congenital hypothyroidism (CH) may transiently show a certain degree of pituitary resistance to levothyroxine (LT4) which, however, normalizes subsequently. However, in some individuals, thyroid-stimulating hormone (TSH) fails...
10.
Cirello V, Colombo C, Karapanou O, Pogliaghi G, Persani L, Fugazzola L
Front Endocrinol (Lausanne)
. 2021 Jan;
11:589340.
PMID: 33488516
Several low penetration susceptibility risk loci or genes have been proposed in recent years with a possible causative role for familial non-medullary thyroid cancer (FNMTC), though the results are still...